Page last updated: 2024-08-26

u 74006f and Graft vs Host Disease

u 74006f has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dzik, WH; Sadrzadeh, SM; Sharifi, S	1

Other Studies

1 other study(ies) available for u 74006f and Graft vs Host Disease

Article	Year
Human plasma and tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma-irradiation. Transfusion medicine (Oxford, England), 2000, Volume: 10, Issue:2 Topics: Antioxidants; Blood Preservation; Cell Survival; Erythrocytes; Evaluation Studies as Topic; Free Radical Scavengers; Gamma Rays; Graft vs Host Disease; Hemolysis; Humans; Lipid Peroxidation; Osmotic Fragility; Oxidative Stress; Plasma; Pregnatrienes; Radiation Tolerance; Radiation-Protective Agents; Thiobarbituric Acid Reactive Substances	2000

Article

Year

Human plasma and tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma-irradiation.

Transfusion medicine (Oxford, England), 2000, Volume: 10, Issue:2

Topics: Antioxidants; Blood Preservation; Cell Survival; Erythrocytes; Evaluation Studies as Topic; Free Radical Scavengers; Gamma Rays; Graft vs Host Disease; Hemolysis; Humans; Lipid Peroxidation; Osmotic Fragility; Oxidative Stress; Plasma; Pregnatrienes; Radiation Tolerance; Radiation-Protective Agents; Thiobarbituric Acid Reactive Substances

2000